Samil Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samil Pharmaceutical Co., Ltd. with three other
companies in this sector in South Korea:
Hwail Pharmaceutical Company Limited
sales of 111.52 billion Korean Won [US$104.49 million]
CKD Bio Corp
(113.01 billion Korean Won [US$105.89 million]
of which 100%
was Pharmaceutical Manufacturing), and
Ctc Bio, Incorporation.
(123.15 billion Korean Won [US$115.39 million]
Samil Pharmaceutical Co., Ltd. reported sales of 96.76 billion Korean Won (US$90.66 million)
December of 2016.
increase of 9.8%
versus 2015, when the company's sales were 88.14 billion Korean Won.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Samil Pharmaceutical Co., Ltd. had sales
of 94.48 billion Korean Won.